全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

新发房颤患者缺血性卒中风险不同方法评估

DOI: 10.11847/zgggws2015-31-09-21, PP. 1179-1181

Keywords: 心房颤动,脑卒中,风险评估,CHA2DS2-VASc评分,CHADS2评分

Full-Text   Cite this paper   Add to My Lib

Abstract:

?目的比较CHADS2和CHA2DS2-VASc2种评分方法对心房颤动(房颤)人群的缺血性脑卒中风险评估的差异。方法采用前瞻性队列研究方法,对143例新发非瓣膜性房颤患者,用CHADS2和CHA2DS2-VASc2种评分方法进行卒中风险评估,比较2种评估方法得分以及卒中危险分层的差异。结果CHADS2平均得分为(1.51±1.28)分,CHA2DS2-VASc平均得分为(2.36±1.97)分,后者明显高于前者(P<0.01);CHA2DS2-VASc评分低危组19例(13.3%),低于CHADS2评分低危组的46例(32.2%)(χ2=11.21,P<0.01);CHA2DS2-VASc评分中危组的32例(22.4%),低于CHADS2评分中危组42例(29.4%)(χ2=4.57,P<0.01);CHA2DS2-VASc评分高危组的92例(64.3%),高于CHADS2评分高危组55例(38.5%)(χ2=20.76,P<0.01);CHADS2评分法中,低度、中度、高度风险组,脑卒中发生例数分别为1、2、3例;CHA2DS2-VASc评分法中,低度、中度、高度风险组脑卒中发生例数分别为0、0、6例。结论与CHADS2评分法比较,CHA2DS2-VASc评估卒中风险中、低危组比例降低,高危组比例升高。

References

[1]  Olesen JB,Lip GY,Hansen ML,et al.Validation of risk stratification:schemes for predicting stroke and thromboembolism in patients with atrial.fibrillation:nationwide cohort study[J].BMJ,2011,342:d124
[2]  Olesen JB,Torp-Pedersen C,Hansen ML,et a1.The value ofthe CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0.1:a nationwide cohort study[J].Thromb Haemost,2012,107:1172-1179.
[3]  Culebras A,Messé SR,Chaturvedi S,et al.Summary of evidence based guideline update:prevention of stroke in nonvalvular atrial fibrillation:report of the Guideline Development Subcommittee of the American Academy of Neurology[J].Neurology,2014,82(8):716-724.
[4]  王洪波,李玉莲,王利清,等.北京市海淀区≥40岁居民脑卒中患病现状及其影响因素[J].中国公共卫生,2014,30(5):583-585.
[5]  张沛光,王文军,肖胜达,等.脑卒中患者生存质量调查[J].中国公共卫生,2014,30(4):508-509.
[6]  中华医学会心血管病学分会,中国老年学学会心脑血管病专业委员会,中国生物医学工程学心律分会,中华医学会心电生理和起搏分会,中国医师协会循证医学专业委员会,心律失常联盟(中国).心房颤动抗凝治疗中国专家共识[J].中华内科杂志,2012,51(11):916-919.
[7]  Camm AJ,Lip GY,De Caterina R,et al.2012 focused update of the ESC guidelines for the management of atrial fibrillation:an update of the 2010 ESC guidelines for the management of atrial fibrillation[J].Eur Heart J,2013,66(1):54.
[8]  Coppens M,Eikelboom JW,Hart RG,et a1.The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2score of l who are unlikely to benefit from oral anticoagulant therapy[J].Eur Heart J,2013,34:170-176.
[9]  Gerth A,Nabauer M,Oeff M,et al.Stroke events in patients with CHADS2scores 0 and 1 in a contemporary population of patients with atrial fibrillation:results from the German AFNET registry[J].Eur Heart J,2013,34(suppl):808.
[10]  Friberg L,Rosenqvist M,Lip GY.Net clinical benefit of warfarin in patients with atrial fibrillation:a report from the Swedish atrial fibrillation cohort study[J].Circulation 2012,125(19):2298-2307.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133